The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects

by Adkison, K.K., Vaidya, S.S., Mehta, A.A., Lee, D.Y., Polli, J.W., Lou, Y., Koo, S.H., Li, L., Lee, E.J.D., Gross, A.S.
Published 2011

Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration

by Adkison, K.K., Vaidya, S.S., Mehta, A.A., Lee, D.Y., Polli, J.W., Humphreys, J.E., Koo, S.H., Li, L., Lee, E.J.D., Gross, A.S., Lou, Y.
Published 2011

Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration

by Adkison, K.K., Vaidya, S.S., Lee, D.Y., Koo, S.H., Li, L., Mehta, A.A., Gross, A.S., Polli, J.W., Humphreys, J.E., Lou, Y., Lee, E.J.D.
Published 2016